Enter to open, tab to navigate, enter to select
Mallinckrodt plc acquisition of assets and subsidiary equity interests of The Medicines Company
| December 18, 2015 • Private Acquisition Agreements • $125 million (subject to purchase price adjustment and additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.